Inhibiting effect of 90Sr-90Y ophthalmic applicator on rat corneal neovascularization induced by sut

来源 :2016年第十届中国医师协会眼科医师分会年会 | 被引量 : 0次 | 上传用户:ok2ejoo
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  AIM:The purpose of the current study was to investigate a practical technique using for inhibiting corneal angiogenesis by a 90Sr-90Y ophthalmic applicator.Methods:90Sr-90Y ophthalmic applicator was detected by radioactive nuclide application treatment healthy protecting standard.The applicator undertook manufacture research,dosimetric medicine research,applicator concavity origin appearance contaminated level,applicator temperature and humidity serviceable range,applicator appearance status,applicator radiation homogeneity,radioautography,the radiogical safety calculation of applicator origin surface.New born vessel rat model was established by sutures around the corneal linbus.The corneal inflammation,dropsy,opacitas,neovascularization were observed by slit lamp.The new vessel lenghth and response area were measured.The datas were statistical analyzed.RESULTS: Low dose radiation can inhibit corneal neovascularization after cornea sutured.The absorbed dose rate of the applicator:0.046Gy/s,it was safe for the treatment of corneal neovascularization.CONCLUSIONS:This technique can be a new pragmatic and safe method.The optimal dose radiation emitting from the applicator can be used potentially in humans.
其他文献
会议
会议
患者女性,45岁.主诉:反复鼻塞伴流脓涕3年余,4 天前发热后出现左眼失明.2016-01-05 收入耳鼻喉科,2016-01-06 以“左眼视神经炎”转入眼科.20 天前因“慢性鼻窦炎发作”于院外间断输液(抗生素:甲硝唑等)治疗,其间发热2 次,体温均为38.3 度左右,自用退热药可缓解.
会议
会议
会议
会议
会议
新生血管性青光眼属于难治性青光眼,由于其病因、病理的复杂性使得对其治疗显得尤为棘手.一般来说,传统的手术效果较差.同时因为新生血管青光眼患者虹膜可以见到大面积的新生血管,术中易出现一些严重的并发症.随着近年显微手术的发展,以及眼科激光、冷冻、抗代谢药物在临床的应用,提高了新生血管性青光眼手术成功率.2010年1月至2015年2月,我院收治新生血管性青光眼18例施行滤过性提高了新生血管性青光眼手术成
会议
会议
会议